MenQuadfi

Medicinal product

(Invented) name

MenQuadfi

Active substance (s)

A gr. Neisseria meningitidis polisacharidas/C gr. Neisseria meningitidis polisacharidas/W gr. Neisseria meningitidis polisacharidas/Y gr. Neisseria meningitidis polisacharidas

Strength

10 µg/10 µg/10 µg/10 µg

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

J07AH08, Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated

Marketing authorisation holder

Sanofi Winthrop Industrie, Prancūzija

Date of authorisation

2020-11-18

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Dozėje (0,5 ml) yra:	0.5 ml
A gr. Neisseria meningitidis polisacharidas	10 µg
C gr. Neisseria meningitidis polisacharidas	10 µg
W gr. Neisseria meningitidis polisacharidas	10 µg
Y gr. Neisseria meningitidis polisacharidas	10 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To
105380	91480	1091480	flakonas	0,5 ml N1	Receptinis	EU/1/20/1483/001	Netiekiama	-	-	No	-	-
105381	91481	1091481	flakonas	0,5 ml N5	Receptinis	EU/1/20/1483/002	Netiekiama	-	-	No	-	-
108685	94791	1094791	flakonas	0,5 ml, švirkštas ir 2 adatos N1	Receptinis	EU/1/20/1483/003	Netiekiama	-	-	No	-	-
108686	94792	1094792	flakonas	0,5 ml N10	Receptinis	EU/1/20/1483/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2020-11-18	Registruotas